Stockreport

Novan Announces Final Week-12 Visit for Last Patient in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum

Novan, Inc.  (NOVN) 
Last novan, inc. earnings: 11/12 04:23 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.novan.com
PDF – Topline data on track for readout before the end of Q2 2021 – – Currently no FDA-approved therapies for the treatment of molluscum – – Potential for NDA filing no l [Read more]